Deborah Ward, PharmD, BCPS, BCOP

Deborah Ward, PharmD, BCPS, BCOP

  • Clinical Pharmacy Specialist
  • Assistant Professor, The University of Tennessee Health Science Center, Department of Clinical Pharmacy and Translational Science

Board Certification

  • BCOP
  • BCPS

Education

  • BS – Chemistry, St Joseph’s University, Philadelphia, PA
  • BS – Pharmacy, Temple University School of Pharmacy, Philadelphia, PA
  • PharmD – Temple University School of Pharmacy, Philadelphia, PA

Post-Graduate Training

  • Pharmacy Practice Residency – Shands Hospital at the University of Florida, Gainesville, Florida
  • Clinical Fellowship Hematology/Oncology – Virginia Commonwealth University, Medical College of Virginia Hospitals, Richmond, Virginia

Honors/Awards

  • 2018 Clinical Care Improvement Award, St Jude Children’s Research Hospital, Memphis, TN as a member of the Chemotherapy Service

Research Interest

  • Supportive Care, Pain and Palliative Care

St. Jude Committee Service

  • Metabolic Infusion Support Service Subcommittee
  • Pharmaceutical Department Residency Committee
  • Operating Room Committee
  • Pain Service and Committee

Pharmacy Organizations/Committee Service

  • Children’s Oncology Group, Renal Committee Pharmacist
  • Hematology Oncology Pharmacist Association, Scope of Care Task Force Member
  • Board of Pharmacy Specialties
    • Non-specialist member: Psychiatric Pharmacy Council
    • Specialist member: Oncology Council
  • Pediatric Pharmacy Advocacy Group
  • American College of Clinical Pharmacy

Selected Publications

Scott JR, Zhou Y, Cheng C, Ward DA, Swanson HD, Molinelli AR, Stewart CF, Navid F, Jeha S, Relling MV, Crews KR. Comparable efficacy with varying dosages of glucarpidase in pediatric oncology patients. Pediatric Blood and Cancer. 2015; 62:1518-1522.

Scott JR, Ward DA, Crews KR, Panetta JC, Relling MV, Navid F. Hypersensitivity reaction to high-dose methotrexate and successful rechallenge in a pediatric patients with osteosarcoma. Pediatr Blood Cancer 61:373-5, 2014.

Christensen AM, Pauley JL, Molinelli AR, Panetta JC, Ward DA, Stewart CF, Hoffman JM, Howard SC, Pui CH, Pappo AS, Relling MV, Crews KR. Resumption of high-dose methotrexate after acute kidney injury and glucarpidase use in pediatric oncology patients. Cancer. 2012;118(17):4321-4330.

Last update: November 2018